Asia Pacific Lung Cancer Screening Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 – Regional Analysis – by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

No. of Pages: 132    |    Report Code: BMIRE00029045    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Lung Cancer Screening Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Lung Cancer Screening Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Lung Cancer Screening Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Lung Cancer Incidence
  • 5.1.2 Increasing Government Support
5.2 Market Opportunities
  • 5.2.1 Structured Lung Cancer Screening Program
5.3 Future Trends
  • 5.3.1 Mobile Lung Cancer Screening Truck
5.4 Impact of Drivers and Restraints

6. Asia Pacific Lung Cancer Screening Market Regional Analysis

6.1 Asia Pacific Lung Cancer Screening Market Overview
6.2 Asia Pacific Lung Cancer Screening Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Lung Cancer Screening Market Forecast Analysis

7. Asia Pacific Lung Cancer Screening Market Analysis – by Cancer Type

7.1 Non-Small Cell Lung Cancer
  • 7.1.1 Overview
  • 7.1.2 Non-Small Cell Lung Cancer: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Small Cell Lung Cancer
  • 7.2.1 Overview
  • 7.2.2 Small Cell Lung Cancer: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Lung Cancer Screening Market Analysis – by Technology

8.1 Low-Dose Computed Tomography
  • 8.1.1 Overview
  • 8.1.2 Low-Dose Computed Tomography: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Chest X-Ray
  • 8.2.1 Overview
  • 8.2.2 Chest X-Ray: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Liquid Biopsy
  • 8.3.1 Overview
  • 8.3.2 Liquid Biopsy: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Lung Cancer Screening Market Analysis – by Age Group

9.1 50 & Older and Below 50
  • 9.1.1 Overview
  • 9.1.2 Liquid Biopsy: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Lung Cancer Screening Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Lung Cancer Screening Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 Asia Pacific Lung Cancer Screening Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Lung Cancer Screening Market Breakdown, by Cancer Type
    • 10.1.1.1.2 China: Asia Pacific Lung Cancer Screening Market Breakdown, by Technology
    • 10.1.1.1.3 China: Asia Pacific Lung Cancer Screening Market Breakdown, by Age Group
  • 10.1.1.2 India: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Lung Cancer Screening Market Breakdown, by Cancer Type
    • 10.1.1.2.2 India: Asia Pacific Lung Cancer Screening Market Breakdown, by Technology
    • 10.1.1.2.3 India: Asia Pacific Lung Cancer Screening Market Breakdown, by Age Group
  • 10.1.1.3 Japan: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Lung Cancer Screening Market Breakdown, by Cancer Type
    • 10.1.1.3.2 Japan: Asia Pacific Lung Cancer Screening Market Breakdown, by Technology
    • 10.1.1.3.3 Japan: Asia Pacific Lung Cancer Screening Market Breakdown, by Age Group
  • 10.1.1.4 Australia: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Lung Cancer Screening Market Breakdown, by Cancer Type
    • 10.1.1.4.2 Australia: Asia Pacific Lung Cancer Screening Market Breakdown, by Technology
    • 10.1.1.4.3 Australia: Asia Pacific Lung Cancer Screening Market Breakdown, by Age Group
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Lung Cancer Screening Market Breakdown, by Cancer Type
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Lung Cancer Screening Market Breakdown, by Technology
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Lung Cancer Screening Market Breakdown, by Age Group

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Lung Cancer Screening Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Intelerad Medical Systems Incorporated
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Nuance Communications Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 GE HealthCare Technologies Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Medtronic Plc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Canon Medical Systems Corp
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Koninklijke Philips NV
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Siemens AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Asia Pacific Lung Cancer Screening Market

  1. Intelerad Medical Systems Incorporated
  2. Nuance Communications Inc                         
  3. GE HealthCare Technologies Inc                  
  4. Medtronic Plc                           
  5. Canon Medical Systems Corp                         
  6. Koninklijke Philips NV
  7. Siemens AG